Company · CIK 1828253
Evaxion A/S
| CIK | 1828253 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | G7 |
| Listed | EVAX (Nasdaq) |
| First annual or quarterly report | 2021-04-07 |
Offerings
9 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-285778 | 2025-03-13 | 2025-12-10 | 4 | |
| 333-291685 | 2025-11-21 | 2025-11-21 | 1 | |
| 333-283304 | 2024-11-18 | 2025-01-31 | 6 | |
| 333-279153 | 2024-05-06 | 2024-08-23 | 5 | |
| 333-276505 | 2024-01-12 | 2024-02-05 | 6 | |
| 333-266050 | 2022-07-07 | 2023-09-13 | 6 | |
| 333-265132 | 2022-05-20 | 2022-10-04 | 3 | |
| 333-260493 | 2021-10-26 | 2021-11-05 | 4 | |
| 333-251982 | 2021-01-08 | 2021-02-05 | 6 |
Filings
43| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-12-10 | 424B5Shelf takedown | 333-285778 | 0001104659-25-119854 |
| 2025-11-21 | F-1Registration filed | 333-291685 | 0001104659-25-114804 |
| 2025-03-26 | 424B5Shelf takedown | 333-285778 | 0001104659-25-028218 |
| 2025-03-24 | EFFECTDeclared effective | 333-285778 | 9999999995-25-000743 |
| 2025-03-13 | F-3Shelf registered | 333-285778 | 0001104659-25-023445 |
| 2025-01-31 | 424B4Final prospectus | 333-283304 | 0001104659-25-007684 |
| 2025-01-29 | EFFECTDeclared effective | 333-283304 | 9999999995-25-000229 |
| 2025-01-28 | F-1/AAmendment | 333-283304 | 0001104659-25-006720 |
| 2024-12-17 | F-1/AAmendment | 333-283304 | 0001104659-24-129424 |
| 2024-12-05 | F-1/AAmendment | 333-283304 | 0001104659-24-125931 |
| 2024-11-18 | F-1Registration filed | 333-283304 | 0001104659-24-120159 |
| 2024-08-23 | 424B4Final prospectus | 333-279153 | 0001104659-24-092246 |
| 2024-08-22 | EFFECTDeclared effective | 333-279153 | 9999999995-24-002600 |
| 2024-08-20 | F-1/AAmendment | 333-279153 | 0001104659-24-091081 |
| 2024-07-22 | F-1/AAmendment | 333-279153 | 0001104659-24-081492 |
| 2024-05-06 | F-1Registration filed | 333-279153 | 0001104659-24-057512 |
| 2024-02-05 | 424B4Final prospectus | 333-276505 | 0001104659-24-010373 |
| 2024-02-01 | EFFECTDeclared effective | 333-276505 | 9999999995-24-000287 |
| 2024-01-31 | F-1/AAmendment | 333-276505 | 0001104659-24-008874 |
| 2024-01-31 | F-1/AAmendment | 333-276505 | 0001104659-24-008585 |
| 2024-01-30 | F-1/AAmendment | 333-276505 | 0001104659-24-008168 |
| 2024-01-12 | F-1Registration filed | 333-276505 | 0001104659-24-003760 |
| 2023-09-13 | 424B4Final prospectus | 333-266050 | 0001104659-23-100475 |
| 2023-08-30 | EFFECTDeclared effective | 333-266050 | 9999999995-23-002528 |
| 2022-10-04 | 424B5Shelf takedown | 333-265132 | 0001104659-22-105608 |
| 2022-08-30 | 424B4Final prospectus | 333-266050 | 0001104659-22-096081 |
| 2022-08-26 | EFFECTDeclared effective | 333-266050 | 9999999995-22-002512 |
| 2022-08-22 | F-1/AAmendment | 333-266050 | 0001104659-22-093396 |
| 2022-07-07 | F-1Registration filed | 333-266050 | 0001104659-22-078077 |
| 2022-06-03 | EFFECTDeclared effective | 333-265132 | 9999999995-22-001687 |
| 2022-05-20 | F-3Shelf registered | 333-265132 | 0001104659-22-063496 |
| 2021-11-05 | 424B4Final prospectus | 333-260493 | 0001104659-21-135073 |
| 2021-11-04 | EFFECTDeclared effective | 333-260493 | 9999999995-21-004212 |
| 2021-11-03 | F-1/AAmendment | 333-260493 | 0001104659-21-133373 |
| 2021-10-26 | F-1Registration filed | 333-260493 | 0001104659-21-129737 |
| 2021-06-25 | DRSDraft made public | 377-05100 | 0001104659-21-085815 |
| 2021-02-05 | 424B4Final prospectus | 333-251982 | 0001104659-21-013059 |
| 2021-02-04 | EFFECTDeclared effective | 333-251982 | 9999999995-21-000437 |
| 2021-02-01 | F-1/AAmendment | 333-251982 | 0001104659-21-010257 |
| 2021-01-25 | F-1/AAmendment | 333-251982 | 0001104659-21-006826 |
| 2021-01-19 | F-1/AAmendment | 333-251982 | 0001104659-21-005403 |
| 2021-01-08 | F-1Registration filed | 333-251982 | 0001104659-21-002525 |
| 2020-10-22 | DRSDraft made public | 377-03693 | 0001104659-20-117187 |